BOK Financial’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.53M | Buy |
16,899
+14,880
| +737% | +$1.25M | 0.02% | 371 |
|
|
2026
Q1 | $162K | Sell |
2,019
-48
| -2% | -$3.96K | ﹤0.01% | 703 |
|
|
2025
Q4 | $176K | Sell |
2,067
-147
| -7% | -$12.1K | ﹤0.01% | 702 |
|
|
2025
Q3 | $172K | Buy |
2,214
+198
| +10% | +$15.5K | ﹤0.01% | 707 |
|
|
2025
Q2 | $158K | Sell |
2,016
-21,055
| -91% | -$1.57M | ﹤0.01% | 721 |
|
|
2025
Q1 | $1.67M | Buy |
23,071
+380
| +2% | +$27.2K | 0.03% | 372 |
|
|
2024
Q4 | $1.67M | Sell |
22,691
-3,804
| -14% | -$266K | 0.03% | 369 |
|
|
2024
Q3 | $1.73M | Sell |
26,495
-11,498
| -30% | -$835K | 0.03% | 363 |
|
|
2024
Q2 | $3.51M | Sell |
37,993
-1,590
| -4% | -$141K | 0.06% | 259 |
|
|
2024
Q1 | $3.73M | Sell |
39,583
-3,237
| -8% | -$272K | 0.07% | 254 |
|
|
2023
Q4 | $3.27M | Buy |
42,820
+1,602
| +4% | +$111K | 0.06% | 263 |
|
|
2023
Q3 | $2.63M | Buy |
41,218
+3,125
| +8% | +$251K | 0.06% | 278 |
|
|
2023
Q2 | $3.59M | Sell |
38,093
-4,439
| -10% | -$386K | 0.07% | 240 |
|
|
2023
Q1 | $3.52M | Sell |
42,532
-4,809
| -10% | -$378K | 0.07% | 241 |
|
|
2022
Q4 | $3.53M | Sell |
47,341
-13,990
| -23% | -$1.08M | 0.07% | 267 |
|
|
2022
Q3 | $5.07M | Sell |
61,331
-2,840
| -4% | -$273K | 0.1% | 195 |
|
|
2022
Q2 | $6.1M | Sell |
64,171
-449
| -0.7% | -$46.5K | 0.12% | 178 |
|
|
2022
Q1 | $7.61M | Sell |
64,620
-2,106
| -3% | -$236K | 0.13% | 170 |
|
|
2021
Q4 | $8.64M | Buy |
66,726
+8,043
| +14% | +$938K | 0.13% | 166 |
|
|
2021
Q3 | $6.64M | Buy |
+58,683
| New | +$6.7M | 0.11% | 189 |
|
|
2021
Q1 | $4.44M | Buy |
53,058
+5,446
| +11% | +$460K | 0.08% | 236 |
|
|
2020
Q4 | $4.34M | Sell |
47,612
-7,042
| -13% | -$584K | 0.08% | 226 |
|
|
2020
Q3 | $4.36M | Sell |
54,654
-19,306
| -26% | -$1.51M | 0.1% | 204 |
|
|
2020
Q2 | $5.11M | Sell |
73,960
-9,791
| -12% | -$696K | 0.12% | 179 |
|
|
2020
Q1 | $5.27M | Sell |
83,751
-2,760
| -3% | -$199K | 0.15% | 147 |
|
|
2019
Q4 | $6.73M | Sell |
86,511
-9,600
| -10% | -$750K | 0.15% | 153 |
|
|
2019
Q3 | $7.04M | Sell |
96,111
-15,660
| -14% | -$1.1M | 0.17% | 139 |
|
|
2019
Q2 | $6.88M | Sell |
111,771
-37,797
| -25% | -$2.29M | 0.17% | 145 |
|
|
2019
Q1 | $9.54M | Sell |
149,568
-13,032
| -8% | -$744K | 0.23% | 108 |
|
|
2018
Q4 | $8.3M | Sell |
162,600
-1,083
| -0.7% | -$54.8K | 0.24% | 105 |
|
|
2018
Q3 | $9.5M | Buy |
163,683
+8,358
| +5% | +$409K | 0.24% | 99 |
|
|
2018
Q2 | $7.54M | Buy |
155,325
+53,031
| +52% | +$2.48M | 0.2% | 124 |
|
|
2018
Q1 | $4.76M | Buy |
102,294
+79,035
| +340% | +$3.43M | 0.14% | 179 |
|
|
2017
Q4 | $873K | Sell |
23,259
-81
| -0.3% | -$2.97K | 0.02% | 522 |
|
|
2017
Q3 | $850K | Sell |
23,340
-306
| -1% | -$11.7K | 0.02% | 531 |
|
|
2017
Q2 | $932K | Buy |
23,646
+456
| +2% | +$16.6K | 0.03% | 490 |
|
|
2017
Q1 | $727K | Sell |
23,190
-28,002
| -55% | -$877K | 0.02% | 559 |
|
|
2016
Q4 | $1.6M | Sell |
51,192
-39
| -0.1% | -$1.26K | 0.05% | 355 |
|
|
2016
Q3 | $2.06M | Buy |
51,231
+18,237
| +55% | +$687K | 0.07% | 316 |
|
|
2016
Q2 | $1.1M | Buy |
32,994
+1,446
| +5% | +$49.5K | 0.04% | 427 |
|
|
2016
Q1 | $928K | Sell |
31,548
-7,320
| -19% | -$202K | 0.03% | 445 |
|
|
2015
Q4 | $1.02M | Sell |
38,868
-51,138
| -57% | -$1.33M | 0.04% | 428 |
|
|
2015
Q3 | $2.13M | Buy |
90,006
+2,904
| +3% | +$70.1K | 0.08% | 279 |
|
|
2015
Q2 | $2.07M | Sell |
87,102
-28,260
| -24% | -$638K | 0.07% | 307 |
|
|
2015
Q1 | $2.74M | Buy |
115,362
+19,386
| +20% | +$435K | 0.09% | 257 |
|
|
2014
Q4 | $2.04M | Buy |
+95,976
| New | +$1.93M | 0.07% | 292 |
|
|
2014
Q1 | – | Sell |
-38,376
| Closed | -$421K | – | 873 |
|
|
2013
Q4 | $421K | Sell |
38,376
-3,978
| -9% | -$44.8K | 0.01% | 664 |
|
|
2013
Q3 | $491K | Buy |
+42,354
| New | +$496K | 0.02% | 580 |
|
Other funds holding EW
BOK Financial's EW Position: Q2 2026 in Review
BOK Financial increased its Edwards Lifesciences (EW) stake by 737% in Q2 2026, buying an estimated $1.25M and bringing the position to 16,899 shares worth $1.53M. The position accounts for 0.02% of the portfolio, ranked #371.
BOK Financial first reported a position in EW in Q3 2013 and has held it in 48 quarters since. The position peaked at $9.54M in Q1 2019. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- BOK Financial held 16,899 shares of Edwards Lifesciences worth $1.53M as of Q2 2026.
- BOK Financial bought 14,880 Edwards Lifesciences shares in Q2 2026, an estimated $1.25M.
- Edwards Lifesciences made up 0.02% of BOK Financial's portfolio in Q2 2026, its #371 holding.
- BOK Financial first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 48 quarters since.
- BOK Financial's Edwards Lifesciences position peaked at $9.54M in Q1 2019.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.